United States · 
What does The Vertical Group invest in?
The Vertical Group invests most often at Series B and Venture (47% of the rounds on record), in sectors such as Medical Technology and Biotechnology.
The Vertical Group highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series B and Venture: 47% of its rounds
- 03
Sole investor in 4 rounds, median $13M
- 04
9 exits from the portfolio
What they do
A venture capital firm that is focused on the fields of medical technology and biotechnology.From their own website
- Type
- VC firm
- Cheque size
- Not stated
- Stages
- SeedSeries A
- Sectors
- Medical TechnologyBiotechnology
- Based in
- Bernards, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first37 appearances
- 2026
1 round
- Sept
- 2017
3 rounds
- Jul
- Jul
- May
- 2015
3 rounds
- Oct
- Jun
- May
- 2014
2 rounds
- Nov
- Apr
- 2013
1 round
- Apr
- 2012
3 rounds
- Apr
- Apr
- Apr
- 2010
2 rounds
- Oct
- Aug
- 2009
2 rounds
- May
- Apr
- 2008
2 rounds
- Nov
- Jun
- 2007
4 rounds
- Jun
- May
- Apr
- Feb
- 2006
5 rounds
- Dec
- May
- Apr
- AprSeed$42MWith 12 others
- Jan
- 2005
1 round
- Oct
- 2004
3 rounds
- Sept
- Aug
- Jan
- 2003
4 rounds
- Oct
- Jul
- Jul
- Jan
- 2002
1 round
- Nov
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 11 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
8 of 16 we have independently watched raise
Galil MedicalMeritage PharmaMonteris MedicalOmadaOutset MedicalRemedy PharmaceuticalsTephaViaCyteBiosurface Technologies Inc. (BioSET)Custom DynamicsOncomedPartner PortalPreventProteinSimpleSilk Road MedicalTornier
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed9 in all
Meritage PharmaBought by Shire$245MFeb 2015
CellBiosciencesBought by Bio-TechneUndisclosedJun 2014
AtheroMedBought by Volcano Corporation$117MMay 2014
OncoMed PharmaceuticalsListed$82MJul 2013
Bacchus VascularBought by CovidienUndisclosedMar 2009
Vascular ArchitectsBought by LeMaitre VascularUndisclosedSept 2007
PhyFlex NetworksBought by CienaUndisclosedSept 2007
OsteoBiologicsBought by Smith & NephewUndisclosedJul 2006
VelocimedBought by St. Jude Medical$74MFeb 2005
An exit counts when it came after the firm's first round in the company. From historical deal records.